Commenting on the partnership, Martin Cannon, President, and Chief Executive Officer of Hemanext, said, “This is a great opportunity for Hemanext to continue to refine and enhance our innovations within Vitalant’s state-of-the-art facility and accelerate our work towards achieving our mission. Additionally, Vitalant’s investment brings significant financial…
Lexington, MA, June 07, 2023 –(PR.com)– Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced a new partnership with Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations. This strategic partnership includes an initial investment by Vitalant and collaboration in research through their new Vitalant Innovation Center, which provides scientific research and translational development expertise to design innovative processes and bring new products to patients across the country.